< 1 minute read
Dec. 16, 2021
TAK-906: A Peripherally-Restricted, Non-BBB Penetrant D2/D3 Receptor Antagonist
TAK-906
peripherally-restricted D2/D3 antagonist oral agent for gastroparesis in Ph. II up to 100 mg PO BID JPET, Clinical Pharmacology Altos Therapeutics / Takeda, Cambridge
Reviewer:
Loading...
